1
2005 Pyridine derivatives R 0380 SAR and Biological Evaluation of Novel trans-3,4-Dimethyl-4-arylpiperidine De- rivatives as Opioid Antagonists. — Compound (XVI) improves the pharmacokinetic properties of LY 255582 and is also efficacious in reducing food consumption in rats. — (DIAZ*, N.; et al.; Bioorg. Med. Chem. Lett. 15 (2005) 17, 3844-3848; Lilly Spain S.A., E-28108 Alcobendas, Madrid, Spain; Eng.) — C. Oppel 50- 135

SAR and Biological Evaluation of Novel trans-3,4-Dimethyl-4-arylpiperidine Derivatives as Opioid Antagonists

Embed Size (px)

Citation preview

Page 1: SAR and Biological Evaluation of Novel trans-3,4-Dimethyl-4-arylpiperidine Derivatives as Opioid Antagonists

2005

Pyridine derivativesR 0380 SAR and Biological Evaluation of Novel trans-3,4-Dimethyl-4-arylpiperidine De-

rivatives as Opioid Antagonists. — Compound (XVI) improves the pharmacokinetic properties of LY 255582 and is also efficacious in reducing food consumption in rats. — (DIAZ*, N.; et al.; Bioorg. Med. Chem. Lett. 15 (2005) 17, 3844-3848; Lilly Spain S.A., E-28108 Alcobendas, Madrid, Spain; Eng.) — C. Oppel

50- 135